What are the Rare Histological Variants of Prostate Cancer?
Prostate cancer is a common cancer among men, primarily presenting as acinar adenocarcinoma. However, there are several rare types of prostate cancer, each with unique characteristics, diagnosis challenges, and treatment responses. This article provides an overview of these rare subtypes to help patients and caregivers understand their nature, prognosis, and treatment options.
Neuroendocrine Prostate Cancers
Neuroendocrine cells don’t produce PSA (prostate-specific antigen), so PSA tests aren’t useful for diagnosing or monitoring these cancers. These cancers are often diagnosed at an advanced stage, requiring a biopsy or TURP (transurethral resection of the prostate) and scans (MRI prostate or PSMA PET CT) to confirm the diagnosis and check for spread.
Small Cell Prostate Cancer
- Description: The most common neuroendocrine prostate cancer, often found with common prostate cancer. It is aggressive and can spread quickly.
- Incidence: Occurs in about 0.3% to 1% of prostate cancers .
- Diagnosis: Requires biopsy and scans.
- Treatment and Prognosis: Typically involves chemotherapy, radiotherapy, and possibly surgery. Hormone therapy is generally not effective. Docetaxel (Taxotere®) is commonly used, but carboplatin or cisplatin with another chemotherapy drug may also be administered. The prognosis is poor, with a median survival of less than 12 months .
Large Cell Prostate Cancer
- Description: Extremely rare and aggressive, often found with common prostate cancer.
- Incidence: Very rare.
- Diagnosis: Confirmed through biopsy and scans.
- Treatment and Prognosis: Primarily involves chemotherapy, with possible surgery and radiotherapy. Hormone therapy may be used if combined with common prostate cancer. Prognosis is poor due to its aggressive nature .
Glandular Prostate Cancers
These cancers develop from the glandular epithelial cells lining the prostate, similar to common prostate cancer but are rare and can be more aggressive.
Ductal Prostate Cancer
- Description: An aggressive form that can spread quickly, often found with common prostate cancer.
- Incidence: Less than 0.5% of prostate cancers .
- Diagnosis: Typically identified through TURP surgery and confirmed with biopsy and scans.
- Treatment and Prognosis: May include surgery, radiotherapy, hormone therapy, and chemotherapy, depending on the cancer's spread. It tends to be more aggressive than common prostate cancer, with a higher likelihood of recurrence after treatment .
Mucinous Prostate Cancer
- Description: Also known as mucinous adenocarcinoma, it is rare and can be mixed with common prostate cancer.
- Incidence: Represents 0.3% of all prostate cancers .
- Diagnosis: Confirmed through PSA tests and biopsy.
- Treatment and Prognosis: Options include surgery, radiotherapy, hormone therapy, and chemotherapy. Recent research suggests it may be slow-growing. The prognosis is generally better than other aggressive variants .
Signet Ring Cell Prostate Cancer
- Description: A very aggressive form that can spread quickly.
- Incidence: Extremely rare, with unclear incidence rates .
- Diagnosis: High PSA levels and biopsy are used for diagnosis. Further tests determine the cancer's origin.
- Treatment and Prognosis: Includes surgery, radiotherapy, hormone therapy, and chemotherapy, depending on the extent of the cancer's spread. Prognosis is generally poor due to its aggressive nature .
Basal Cell Prostate Cancer
- Description: Also known as adenoid cystic or basaloid carcinoma, it is rare and may coexist with common prostate cancer.
- Incidence: Very rare, with limited cases documented.
- Diagnosis: PSA tests are typically not useful. Diagnosis often occurs through TURP surgery, followed by biopsy and scans.
- Treatment and Prognosis: Treatment options include surgery, radiotherapy, and chemotherapy. Prognosis is uncertain due to varying reports on its aggressiveness .
Transitional Cell Prostate Cancer
- Description: Also known as urothelial carcinoma, this cancer starts in the cells lining the urethra.
- Incidence: Very rare.
- Diagnosis: Often identified through TURP surgery, biopsy, and scans.
- Treatment and Prognosis: Depending on the cancer’s spread, treatment may involve surgery, radiotherapy, and various chemotherapy regimens. Prognosis depends on the stage at diagnosis .
Prostate Sarcomas
These rare cancers develop from smooth muscle cells in the prostate.
Leiomyosarcoma
- Description: The most common type in men over 40, it is aggressive and can spread.
- Incidence: Extremely rare.
- Diagnosis: PSA tests may not be useful. Diagnosis often involves TURP surgery and biopsy, followed by scans.
- Treatment and Prognosis: Includes surgery, radiotherapy, and chemotherapy. The prognosis is poor due to its aggressive nature .
Rhabdomyosarcoma
- Description: Mostly found in children but rare in adults, it is very aggressive.
- Incidence: Extremely rare.
- Diagnosis: Typically identified through TURP surgery and biopsy, with subsequent scans.
- Treatment and Prognosis: Treatment options include surgery, radiotherapy, and chemotherapy. Prognosis is generally poor due to its aggressive nature .
Other Rare Prostate Cancers
Pleomorphic Giant Cell Carcinoma
- Description: Contains large, abnormal tumor cells with prominent nucleoli.
- Incidence: Very rare, with limited data on incidence .
- Diagnosis: Identified by the presence of pleomorphic giant cells and confirmed with specific stains.
- Treatment and Prognosis: Often more aggressive than conventional prostate cancer, with poor outcomes .
Urothelial Carcinoma
- Description: Originates from the urothelial cells lining the prostate ducts.
- Incidence: Very rare, occurring in a small percentage of prostate cancer cases.
- Diagnosis: Confirmed through histopathological examination and specific markers like CK7 and CK20.
- Treatment and Prognosis: Prognosis depends on the presence of stromal invasion. Non-invasive cases have a better outlook, while invasive cases have poor survival rates .
Adenosquamous and Squamous Cell Carcinoma
- Description: These cancers show squamous differentiation, sometimes mixed with glandular components.
- Incidence: Rare, with limited cases documented.
- Diagnosis: Lack of PSA expression in squamous cells helps in diagnosis.
- Treatment and Prognosis: Prognosis is generally poor, with low survival rates despite aggressive treatment .
Lymphoepithelioma-like Carcinoma
- Description: Very rare, resembling lymphoepithelioma of the nasopharynx.
- Incidence: Extremely rare, with only a few cases reported.
- Diagnosis: Identified by syncytial growth amid a dense lymphocytic background.
- Treatment and Prognosis: Prognosis is poor, with patients often surviving only a few months after diagnosis .
Words of Wisdom from a Consultant Urologist
Recognizing and accurately diagnosing rare variants of prostate cancer is crucial due to their distinct clinical behaviors and treatment responses. Early and precise identification can significantly impact patient management and outcomes. As these variants often present diagnostic challenges, continuous advancements in histopathological techniques and molecular analyses are essential. For urologists and oncologists, staying informed about these rare entities can enhance diagnostic accuracy and therapeutic strategies.
Articles used for the write up of rare prostate cancer that can be helpful in your research
.webp)